{
  "type": "hyp",
  "text": "When cells were stimulated with anti-CD3 mAb or PMA/A23187 a complex formation of NF-AT AP-1 and NF-kappa B sequences was induced.\n",
  "self": {
    "NER": {
      "answers": [
        "mAb",
        "PMA/A23187"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was used to induce a complex formation of NF-AT AP-1 and",
          "What is the name of the anti-CD3 mAb?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "cells",
        "anti-CD3 mAb",
        "PMA/A23187",
        "a complex formation",
        "NF-AT",
        "NF-kappa B sequences"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was stimulated with anti-CD3 mAb?",
          "What was used to induce a complex formation of NF-AT AP-1 and",
          "What is the name of the anti-CD3 mAb?",
          "What was induced when cells were stimulated with anti-CD3 mAb?",
          "What type of AP-1 was induced when cells were stimulated with anti-CD3",
          "What was induced when cells were stimulated with anti-CD3 mAb?"
        ]
      }
    }
  },
  "asked": {
    "What enhanced the complex formation with NF-AT AP-1 and CLE0 sequences": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.1847248077392578,
        "ground_truth": {
          "PGE2": {
            "bertscore": 0.6522912979125977,
            "f1": 0
          }
        }
      }
    },
    "What sequences were added to the complex formation of rat cells when activated by anti-": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "NF-AT AP-1 and NF-kappa B",
        "answerability": 0.5601173043251038,
        "ground_truth": {
          "CLE0 sequences": {
            "bertscore": 0.6944810152053833,
            "f1": 0
          }
        }
      }
    },
    "What was used to activate the complex formation?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "anti-CD3 mAb or PMA/A23187",
        "answerability": 0.9224631190299988,
        "ground_truth": {
          "mAb": {
            "bertscore": 0.6879438757896423,
            "f1": 0.4
          }
        }
      }
    },
    "What stimulation enhanced complex formation?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.506462574005127,
        "ground_truth": {
          "PMA/A23187": {
            "bertscore": 0.6270791292190552,
            "f1": 0
          }
        }
      }
    },
    "What did PGE2 enhance?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0022819042205810547,
        "ground_truth": {
          "the complex formation": {
            "bertscore": 0.6839048862457275,
            "f1": 0
          }
        }
      }
    },
    "What AP-1 and CLE0 sequences were activated by anti-CD3": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.41018742322921753,
        "ground_truth": {
          "NF-AT": {
            "bertscore": 0.7010692954063416,
            "f1": 0
          }
        }
      }
    },
    "What was activated by anti-CD3 mAb?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.29596537351608276,
        "ground_truth": {
          "the cells": {
            "bertscore": 0.6629190444946289,
            "f1": 0
          }
        }
      }
    },
    "What two things activated the complex formation?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "anti-CD3 mAb or PMA/A23187",
        "answerability": 0.8181594014167786,
        "ground_truth": {
          "either anti-CD3 mAb or PMA/A23187 stimulation": {
            "bertscore": 0.9238846898078918,
            "f1": 0.8
          }
        }
      }
    }
  }
}